An observational study in Polycystic Ovary Syndrome, sponsored by Irmandade da Santa Casa de Misericordia de Sao Paulo. Status unknown at 1 site in Brazil. Open to female participants aged 12 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-03-20.
Sponsored by Irmandade da Santa Casa de Misericordia de Sao Paulo · Observational
Metabolic profile in women of different body composition with polycystic ovary syndrome.
Will be performed case-control study with women with Polycystic Ovary Syndrome, according to the Rotterdam criteria and body mass index between 18 to 29.9. The control group will consist of women without Polycystic Ovary Syndrome, with a body mass index of 18 to 29.9 and no other comorbidities. In both groups collect anthropometric data such as age, weight, height, waist circumference and blood pressure. Exams will be requested: metabolic profile (total cholesterol (mg/dL) and fractions, triglycerides (mg/dL), blood count, liver function (U/L) and classical glycemic index (mg/dL); hormonal profile - insulin (uIU/ml), luteinizing hormone (IU/L), follicle stimulating hormone (IU/L), thyreostimulating hormone (uIU/ML), total and free testosterone (ng/ml), 17-hydroxyprogesterone (ng/ml), dehydroepiandrosterone (ng/ml), prolactin (ug/ml). Body composition (BMI) will be performed by absorption technique of two low energy beams emitted by X-ray - full body densitometry (DEXA). Expected result: To evaluate visceral fat and truncal of patients with diagnosis of Polycystic Ovary Syndrome without obesity.
975 studies on the registry are indexed under Polycystic Ovary Syndrome; 177 are open to participants now.
This study's planned enrollment of 90 is below the median of 106 across 229 observational studies indexed under Polycystic Ovary Syndrome.
Browse Polycystic Ovary Syndrome studies →Irmandade da Santa Casa de Misericordia de Sao Paulo is the lead sponsor of 8 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Will be performed case-control study with women with Polycystic Ovary Syndrome, according to the Rotterdam criteria and body mass index between 18 to 29.9. The control group will consist of women without Polycystic Ovary Syndrome, with a body mass index of 18 to 29.9 and no other comorbidities.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Metabolic profile
total cholesterol (mg/dL) and fractions, triglycerides (mg/dL) will estimate
Time frame: 12 months
Classical glycemic index
Classical glycemic index (mg/dL) will estimate
Time frame: 12 months
Liver function
Liver function (U/L) will estimate
Time frame: 12 months
luteinizing hormone
luteinizing hormone (IU/L) will estimate
Time frame: 12 months
Hormonal profile - insulin
Hormonal profile - insulin (uIU/ml) will estimate
Time frame: 12 months
Follicle stimulating hormone
Follicle stimulating hormone (IU/L) will estimate
Time frame: 12 months
thyreostimulating hormone
thyreostimulating hormone (uIU/ML) will estimate
Time frame: 12 months
Total and free testosterone
Total and free testosterone (ng/ml) will estimate
Time frame: 12 months
17-hydroxyprogesterone
17-hydroxyprogesterone (ng/ml) will estimate
Time frame: 12 months
Dehydroepiandrosterone
Dehydroepiandrosterone (ng/ml) will estimate
Time frame: 12 months
Prolactin
Prolactin (ug/ml) will estimate
Time frame: 12 months
DEXA
Body composition will measure by DEXA scan
Time frame: 12 months
Plan to share: No — When I have finished my recruitment and analysis of the results.
The record gives a start of Jan 2014, a primary completion of Sep 2017 and a completion of Dec 2017. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Irmandade da Santa Casa de Misericordia de Sao Paulo